Abstract
Background
Methods
Results
Conclusion
Level of evidence
Keywords
What is already known?
- •NSAID use post-arthroscopic rotator cuff repair is controversial, with concerns about potential effects on tendon healing.
- •However, current standard-of-care has significant limitations.
What are the new findings?
- •NSAID use post-arthroscopic rotator cuff repair does not increase retear rates and offers comparable clinical outcomes with the current standard of care
- •NSAIDs appear to be a safe and effective modality for pain-relief post-arthroscopic rotator cuff repair requiring oral analgesics, especially on discharge.
1. Introduction
- Sinatra R.S.
- Torres J.
- Bustos A.M.
- Ritchie ED
- Tong D
- Chung F
- Norris AM
- Miniaci A
- Vairavanathan SD
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Sivasundaram L
- Trivedi NN
- Kim CY
- Du J
- Liu RW
- Voos JE
- et al.
- Hällfors E
- Saku SA
- Mäkinen TJ
- Madanat R
- Sinatra R.S.
- Torres J.
- Bustos A.M.
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Cohen DB
- Kawamura S
- Ehteshami JR
- Rodeo SA
- Connizzo BK
- Yannascoli SM
- Tucker JJ
- Caro AC
- Riggin CN
- Mauck RL
- et al.
- Ekhtiari S
- Horner NS
- Shanmugaraj A
- Duong A
- Simunovic N
- Ayeni OR
- Paul RW
- Szukics PF
- Brutico J
- Tjoumakaris FP
- Freedman KB
2. Methods
2.1 Search strategy
2.2 Selection criteria
2.3 Data extraction
2.4 Definition of NSAID and control groups
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
2.5 Follow-up durations for retear rates, VAS score, and functional outcomes
- Miller BS
- Downie BK
- Kohen RB
- Kijek T
- Lesniak B
- Jacobson JA
- et al.
- Kurowicki J
- Berglund DD
- Momoh E
- Disla S
- Horn B
- Giveans MR
- et al.
- Stiglitz Y
- Gosselin O
- Sedaghatian J
- Sirveaux F
- Molé D
2.6 Statistical analysis
- Wan X
- Wang W
- Liu J
- Tong T
- Higgins JP
- Thompson SG
- Deeks JJ
- Altman DG
2.7 Quality assessment
3. Results
3.1 Literature retrieval
- Jildeh TR
- Abbas MJ
- Hasan L
- Moutzouros V
- Okoroha KR
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
3.2 Assessment of risk of bias
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
3.3 Study characteristics
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
Study | Study period | Study design | Group | Baseline sample size | Follow-up duration (months) | Institution (country) | Institution standard-of-care pain relief (pre/intra/post-operative) | Rehabilitation protocol | Patient demographics | Tear details |
Rouhani et al., 2014 | 2009–2012 | Case control study | Celecoxib (NSAID group) | 30 | 0.07 (2 days) | Shohada Educational Hospital, Tabriz University of Medical Sciences, Tabriz, Iran | Pre-operative: Celecoxib (NSAID group only) Post-operative: Acetaminophen 500mg/Hydrocodone 5 mg tablet as needed IV petedine as needed (if severe) | NR | Sex (Male): 24 (80%) Age: 48.4 ± 11.6 | Tear size (mm): 24 ± 3 |
Placebo (Control group) | 30 | 0.07 (2 days) | NR | Sex (Male): 22 (73.3%) Age: 47.2 ± 12 | Tear size (mm): 25 ± 7 | |||||
Oh et al., 2017 | 2011–2012 | RCT | Celecoxib | 60 | 24 | Seoul National University Bundang Hospital (Korea) | Pre-operative: None prescribed Post-operative: Subacromial patient-controlled analgesia (ropivacaine) Oxycodone as-needed | 5 weeks abduction brace Passive ROM immediately after surgery | Sex (Male): 17 Age: 61.5 ± 8.4 Hand Dominance (Right): 41 Previous Trauma: 24 Comorbidities: DM (9), HTN (20), Smoker (3) | Tear size: - Retraction (mm): 18.3 ± 10.5 - Anteroposterior dimension (mm): 17.0 ± 0.5 |
Ibuprofen | 60 | Sex (Male): 22 Age: 61.2 ± 9.5 Hand Dominance (Right): 39 Previous Trauma: 19 Comorbidities: DM (5), HTN (21), Smoker (11) Combined: Age: 61.35 ± 8.93 | Tear size: - Retraction (mm): 17.6 ± 9 - Anteroposterior dimension (mm): 16.5 ± 7.6 Combined: Retraction tear size: 18 ± 9.7 | |||||||
Tramadol | 54 | Sex (Male): 24 Age: 59.6 ± 9.2 Hand Dominance (Right): 48 Previous Trauma: 25 Comorbidities: DM (6), HTN (21), Smoker (7) | Tear size: - Retraction (mm): 16.1 ± 8.2 - Anteroposterior dimension (mm): 15.9 ± 8.2 | |||||||
Kraus et al., 2020 | 2012–2016 | Retrospective study | Ibuprofen (NSAID group) | 182 | 24 | Tufts university school of medicine (USA) | Pre-operative: NR Post-operative: Opioid medication as needed | NR | Sex (male): 94 (51%) Age: 55.93 ± 9.72 BMI: 27.9 ± 10.6 Comorbidities: DM 9 (5%) | No. of tendons involved: 1: 81 (44.5%) 2: 72 (39.6%) 3: 27 (14.8%) 4: 2 (1.1%) Missing: 6 |
No NSAID group (Control) | 281 | 24 | Sex (male): 162 (58%) Age: 57.01 ± 9.13 BMI: 28 ± 8.73 Comorbidities: DM: 10 (4%) | No. of tendons involved: 1: 82 (42.3%) 2: 77 (39.7%) 3: 31 (16%) 4: 4 (2.1%) Missing: 89 | ||||||
Burns et al., 2021 | 2014–2018 | RCT | Celecoxib | 40 | 12 | SSM Health DePaul Hospital and University of Southern California (USA) | Pre-operative: NR Post-operative: Inter-scalene regional block Oxycodone/acetominophen, hydrocodone/acetaminophen, codeine or tramadol as-needed | 3 weeks abduction sling Passive ROM immediately after surgery | Sex (Male): 11 Age: 54 ± 7.1 BMI: 32.5 ± 7.5 Hand Dominance (Right): 11 Comorbidities: DM (1), HTN (9), Smoker (9) | Tear size (mm): 17.9 ± 3.84 Tendon torn: SSP or ISP |
Placebo | 39 | Sex (Male): 10 Age: 56.8 ± 7.4 BMI: 32.5 ± 5.8 Hand Dominance (Right): 15 Comorbidities: DM (5), HTN (10), Smoking (8) | Tear size (mm): 14.04 ± 5.62a Tendon torn: SSP or ISP | |||||||
Sivasundaram et al., 2021 | 2019–2020 | RCT | Ketorolac | 20 | 7.5 | Case Western Reserve University and University Hospitals of Cleveland (USA) | Pre-operative: Interscalene regional block (bupivacaine with epinephrine) Post-operative: Oxycodone/acetminophen as-needed | NR | Sex (Male): 15 Age: 55.7 ± 8.2 BMI: 32.9 ± 6.5 Comorbidities: DM (4), HTN (12) | Tear morphology (n): Partial-thickness (3), Full-thickness (5), Massive (4) |
Control | 19 | Sex (Male): 11 Age: 55.7 ± 12.9 BMI: 29.2 ± 6.1 Comorbidities DM (1), HTN (4), CHF (1), Hypothyroidism (1), Depression (5) | Tear morphology (n): Partial-thickness (1), Full-thickness (6), Massive (2) | |||||||
Tangtiphaiboontana et al., 2021 | 2016–2019 | RCT | Ibuprofen | 51 | 12 | University of California (USA) | Pre-operative: NR Post-operative: Hydrocodone/acetominophen as needed | 6 weeks abduction sling Passive ROM immediately after surgery | Sex (Male): 29 Age: 57.7 ± 10.8 Hand Dominance (Right): 46 | Tear morphology (n): Small (21), Medium (23), Large (3), Massive (3) Tendon torn (n): SSP (40), ISP (12), Teres minor (0), Subscapularis (25) |
Placebo | 50 | Sex (Male): 29 Age: 56.9 ± 13.8 Hand Dominance (Right): 45 | Tear morphology (n): Small (19), Medium (24), Large (6), Massive (1) Tendon torn (n): SSP (42), ISP (5), Teres minor (0), Subscapularis (27) |
3.3.1 Patient demographics and follow-up
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
3.3.2 Tear details
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
3.4 Outcome details
Study | Group | Analgesic used | Sample size at final follow-up | Retear rates (%) | Pain outcomes | Function outcomes | Rescue medication/opioid use (final follow-up) | ||||||
Rates (%) | Criteria for retear diagnosis | Follow-up duration for retear rates in months (≥6 months) | VAS score at early post-op period | Follow-up duration for early VAS score in weeks (<3 months) | VAS score at late post-op period | Follow-up duration for late VAS score in months (≥12 months) | ASES score (final follow-up, ≥12 months) | Dosage/number of pills | Rates (%) | ||||
Rouhani et al., 2014 | NSAID | Celecoxib | 30 | NR | 3.6 ± 0.8 (n = 30) | 0.3 week (2 days) | NR | NR | NR | NR | |||
Control | Placebo | 30 | 5.1 ± 1.4 (n = 30) | NR | 18/30 (60%) | ||||||||
Oh et al., 2017 | NSAID | Celecoxib | 30 | 11/30 (37%) | Sugaya type IV or V on MRI or full/partial-thickness tear on USG | 24 months | 2.8 ± 2.1 (n = 53) | 2 weeks | 0.9 ± 1.9 (n = 30) | 24 months | 87.6 ± 11.4 (n = 30) | No. of pills: 3.4 ± 1.6 | 27/53 (51%) |
Ibuprofen | 27 | 2/27 (7%) | 3.2 ± 1.9 (n = 55) | 0.6 ± 1.1 (n = 27) | 93 ± 6.6 (n = 27) | No. of pills: 3.9 ± 1.9 | 30/55 (55%) | ||||||
Control | Tramadol | 25 | 1/25 (4%) | 3.2 ± 1.9 (n = 54) | 0.8 ± 1.5 (n = 25) | 87 ± 11.5 (n = 25) | No. of pills: 4.1 ± 1.7 | 36/54 (67%) | |||||
Burns et al., 2021 | NSAID | Celecoxib | 22 | 10/20 (50%) | Sugaya type IV or V on MRI | 12 months | NR | 0.86 ± 1.59 (n = 22) | 12 months | 92.9 ± 11.9 (n = 22) | NR | NR | |
Control | Placebo | 23 | 6/20 (30%) | 0.72 ± 1.58 (n = 23) | 88.2 ± 22.9 (n = 23) | NR | NR | ||||||
Sivasundaram et al., 2021 | NSAID | Ketorolac | 20 | 2/11(18%) | Full/partial-thickness tear on MRI | 7.9 months | 2.98 ± 2.50 (n = 20) | 2 weeks | NR | NR | No. of pills: 8.82 ± 3.63 | 5/20 (25%) | |
Control | Control | 19 | 3/11 (27%) | 4.66 ± 0.2.49 (n = 19) | No. of pills: 19.42 ± 2.92 | 13/19 (68.4%) | |||||||
Tangtiphaiboontana et al., 2021 | NSAID | Ibuprofen | 51 | 7/43 (16%) | Full/partial-thickness tear on USG | 12 months | 2.1 ± 2.0 (n = 49) | 6 weeks | 0.4 ± 0.8 (n = 41) | 12 months | 93.4 ± 8.1 (n = 39) | Dosage: 168.3 ± 96 MME | NR |
Control | Placebo | 50 | 13/43 (30%) | 2.5 ± 2.1 (n = 50) | 0.7 ± 1.2 (n = 39) | 90.9 ± 11.2 (n = 36) | Dosage: 210.9 ± 104 MME | NR | |||||
Kraus et al., 2021 | NSAID | Ibuprofen | 182 | NR | NR | 1.3 ± 0.4 (n = 182) | 24 months | 85.9 ± 4.5 (n = 182) | NR | NR | |||
Control | Opioids (not specified) | 281 | 1.2 ± 0.4 (n = 281) | 85.6 ± 4.2 (n = 281) | NR | NR |
3.5 Meta-analysis of retear rates
3.5.1 Retear rates (NSAID vs. control)
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
3.6 Meta-analysis of pain outcomes
3.6.1 VAS score (early and late follow-up)
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
3.7 Meta-analysis of functional outcomes
3.7.1 ASES score
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
3.8 Subgroup analysis
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
4. Discussion
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Ekhtiari S
- Horner NS
- Shanmugaraj A
- Duong A
- Simunovic N
- Ayeni OR
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Singh G
- Fort JG
- Goldstein JL
- Levy RA
- Hanrahan PS
- Bello AE
- et al.
4.1 Retear rates
- Cohen DB
- Kawamura S
- Ehteshami JR
- Rodeo SA
- Connizzo BK
- Yannascoli SM
- Tucker JJ
- Caro AC
- Riggin CN
- Mauck RL
- et al.
- Hein J
- Reilly JM
- Chae J
- Maerz T
- Anderson K
- Kwon J
- Kim SH
- Lee YH
- Kim TI
- Oh JH
- Lee YS
- Jeong JY
- Park CD
- Kang SG
- Yoo JC
- Burns KA
- Robbins LM
- LeMarr AR
- Childress AL
- Morton DJ
- Wilson ML
- Saltzman BM
- Zuke WA
- Go B
- Mascarenhas R
- Verma NN
- Cole BJ
- et al.
- Gallagher BP
- Bishop ME
- Tjoumakaris FP
- Freedman KB
- Dolkart O
- Liron T
- Chechik O
- Somjen D
- Brosh T
- Maman E
- et al.
- Su B.
- O'Connor J.P.
- Gwee KA
- Goh V
- Lima G
- Setia S
4.2 Pain outcomes
- Pitchon DN
- Dayan AC
- Schwenk ES
- Baratta JL
- Viscusi ER
- Axelsson K
- Gupta A
- Johanzon E
- Berg E
- Ekbäck G
- Rawal N
- et al.
- Tashjian RZ
- Deloach J
- Porucznik CA
- Powell AP
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
- Sivasundaram L
- Mengers S
- Trivedi NN
- Strony J
- Salata MJ
- Voos JE
- et al.
- Tangtiphaiboontana J
- Figoni AM
- Luke A
- Zhang AL
- Feeley BT
- Ma CB
- Rouhani A
- Tabrizi A
- Elmi A
- Abedini N
- Mirza Tolouei F
4.3 Functional outcomes
- Cvetanovich GL
- Gowd AK
- Liu JN
- Nwachukwu BU
- Cabarcas BC
- Cole BJ
- et al.
- Kraus NR
- Garvey KD
- Higgins LD
- Matzkin E
4.4 Limitations
- Inderhaug E
- Kollevold KH
- Kalsvik M
- Hegna J
- Solheim E
5. Conclusion
Declaration of competing interest
Appendix A. Supplementary data
- Multimedia component 1
References
- Pain management after major orthopaedic surgery: current strategies and new concepts.J Am Acad Orthop Surg. 2002; 10 (2002/04/04): 117-129https://doi.org/10.5435/00124635-200203000-00007
- Suprascapular nerve block for postoperative pain relief in arthroscopic shoulder surgery: a new modality?.Anesth Analg. 1997 Jun; 84 (PMID: 9174311): 1306-1312https://doi.org/10.1097/00000539-199706000-00024
- Do Selective COX-2 Inhibitors affect pain control and healing after arthroscopic rotator cuff repair? A preliminary study.Am J Sports Med. 2018 Mar; 46: 679-686https://doi.org/10.1177/0363546517744219
- Oral ketorolac as an adjuvant agent for postoperative ain control after arthroscopic rotator cuff repair: A prospective, randomized, controlled study.J Am Acad Orthop Surg. 2021 Dec 15; 29 (PMID: 34047723): e1407-e1416https://doi.org/10.5435/JAAOS-D-20-01432
- Emergency department utilization after elective hip arthroscopy.Arthroscopy. 2020 Jun; 36 (Epub 2020 Feb 26. PMID: 32109576): 1575-1583.e1https://doi.org/10.1016/j.arthro.2020.02.008
- A consultation phone service for patients with total joint arthroplasty may reduce unnecessary emergency department visits.J Arthroplasty. 2018; 33 (Epub 2017 Oct 31. PMID: 29157787): 650-654https://doi.org/10.1016/j.arth.2017.10.040
- Editorial commentary: postoperative pain management after arthroscopic rotator cuff repair: the journey to pain relief.Arthroscopy. 2020; 36 (2020/05/07): 1251-1252https://doi.org/10.1016/j.arthro.2020.02.030
- Current concepts in sports medicine: the use of COX-2 specific inhibitors and the emerging trends in arthroscopic surgery.Orthopedics. 2000; 23: S769-S772https://doi.org/10.3928/0147-7447-20000702-06
- Comparative toxicity of nonsteroidal anti-inflammatory drugs.Am J Med. 1999; 107 (discussion 46S-47S): 37S-46Shttps://doi.org/10.1016/s0002-9343(99)00366-6
- The effects of nonsteroidal anti-inflammatory medications after rotator cuff surgery: a randomized, double-blind, placebo-controlled trial.J Shoulder Elbow Surg. 2021 Sep; 30 (Epub 2021 Jun 24. PMID: 34174448): 1990-1997https://doi.org/10.1016/j.jse.2021.05.018
- Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing.Am J Sports Med. 2006 Mar; 34 (Epub 2005 Oct 6. PMID: 16210573): 362-369https://doi.org/10.1177/0363546505280428
- The detrimental effects of systemic Ibuprofen delivery on tendon healing are time-dependent.Clin Orthop Relat Res. 2014 Aug; 472 (PMID: 23982408; PMCID: PMC4079885): 2433-2439https://doi.org/10.1007/s11999-013-3258-2
- Narcotic prescriptions following knee and shoulder arthroscopy: A survey of the Arthroscopy Association of Canada.Cureus. 2020 Apr 27; 12 (PMID: 32483506; PMCID: PMC7255063): e7856https://doi.org/10.7759/cureus.7856
- Postoperative multimodal pain management and opioid consumption in arthroscopy clinical trials: A systematic review.Arthrosc Sports Med Rehabil. 2021 Dec 17; 4 (PMID: 35494281; PMCID: PMC9042766): e721-e746https://doi.org/10.1016/j.asmr.2021.09.011
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ. 2021; 372: n71https://doi.org/10.1136/bmj.n71
- Rayyan—a web and mobile app for systematic reviews.Syst Rev. 2016; 5: 210
- Healing rates after rotator cuff repair for patients taking either celecoxib or placebo: a double-blind randomized controlled trial.JSES Int. 2020 Dec 8; 5 (PMID: 33681844; PMCID: PMC7910746): 247-253https://doi.org/10.1016/j.jseint.2020.10.011
- Effects of preoperative non-steroidal anti-inflammatory drugs on pain mitigation and patients’ shoulder performance following rotator cuff repair.Adv Pharm Bull. 2014 Dec; 4 (Epub 2014 Aug 10. PMID: 25436192; PMCID: PMC4137426): 363-367https://doi.org/10.5681/apb.2014.053
- Ibuprofen use did not affect outcome metrics after arthroscopic rotator cuff repair.Arthrosc Sports Med Rehabil. 2021 Feb 24; 3 (PMID: 34027460; PMCID: PMC8129460): e491-e497https://doi.org/10.1016/j.asmr.2020.11.004
- When do rotator cuff repairs fail? Serial ultrasound examination after arthroscopic repair of large and massive rotator cuff tears.Am J Sports Med. 2011 Oct; 39 (Epub 2011 Jul 7. PMID: 21737833): 2064-2070https://doi.org/10.1177/0363546511413372
- Time to failure after rotator cuff repair: a prospective imaging study.J Bone Joint Surg Am. 2013 Jun 5; 95 (PMID: 23780533): 965-971https://doi.org/10.2106/JBJS.L.00708
- Speed of recovery after arthroscopic rotator cuff repair.J Shoulder Elbow Surg. 2017 Jul; 26 (Epub 2017 Jan 26. PMID: 28131695): 1271-1277https://doi.org/10.1016/j.jse.2016.11.002
- The factors affecting pain pattern after arthroscopic rotator cuff repair.Clin Orthop Surg. 2014; 6: 392-400https://doi.org/10.4055/cios.2014.6.4.392
- Pain after shoulder arthroscopy: a prospective study on 231 cases.Orthop Traumatol Surg Res. 2011 May; 97 (Epub 2011 Apr 1. PMID: 21458397): 260-266https://doi.org/10.1016/j.otsr.2011.02.003
- Doing Meta-Analysis with R: A Hands-On Guide. 1st ed. Chapman and Hall/CRC, 2021
Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane 2021.
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.BMC Med Res Methodol. 2014 Dec 19; 14 (PMID: 25524443; PMCID: PMC4383202): 135https://doi.org/10.1186/1471-2288-14-135
- Measuring inconsistency in meta-analyses.BMJ. 2003 Sep 6; 327 (PMID: 12958120; PMCID: PMC192859): 557-560https://doi.org/10.1136/bmj.327.7414.557
- Meta-analysis in clinical trials.Contr Clin Trials. 1986; 7: 177-188https://doi.org/10.1016/0197-2456(86)90046-2
- The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.2013
- Multimodal nonopioid pain protocol provides better or equivalent pain control compared to opioid analgesia following arthroscopic rotator cuff surgery: A prospective randomized controlled trial.Arthroscopy. 2022 Apr; 38 (Epub 2021 Nov 25. PMID: 34838987): 1077-1085https://doi.org/10.1016/j.arthro.2021.11.028
- Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.Clin Ther. 2001 Feb; 23 (PMID: 11293556): 228-241https://doi.org/10.1016/s0149-2918(01)80005-9
- SUCCESS-I Investigators. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.Am J Med. 2006 Mar; 119 (Erratum in: Am J Med. 2006 Sep;119(9):801. PMID: 16490472): 255-266https://doi.org/10.1016/j.amjmed.2005.09.054
- Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.JAMA. 2000 Sep 13; 284 (PMID: 10979111): 1247-1255https://doi.org/10.1001/jama.284.10.1247
- Risk factors for retear after arthroscopic repair of full-thickness rotator cuff tears using the suture bridge technique: classification system.Arthroscopy. 2016; 32 (2016/05/23): 2191-2200https://doi.org/10.1016/j.arthro.2016.03.012
- Retear Rates After Arthroscopic single-row, double-row, and suture bridge rotator cuff repair at a minimum of 1 year of imaging follow-up: A systematic review.Arthroscopy. 2015 Nov; 31 (Epub 2015 Jul 15. PMID: 26188783): 2274-2281https://doi.org/10.1016/j.arthro.2015.06.004
- The rotator cuff healing index: A new scoring system to predict rotator cuff healing after surgical repair.Am J Sports Med. 2019 Jan; 47 (Epub 2018 Nov 28. PMID: 30485753): 173-180https://doi.org/10.1177/0363546518810763
- Evaluation of the risk factors for a rotator cuff retear after repair surgery.Am J Sports Med. 2017 Jul; 45 (Epub 2017 Mar 20. PMID: 28319431): 1755-1761https://doi.org/10.1177/0363546517695234
- Does early motion lead to a higher failure rate or better outcomes after arthroscopic rotator cuff repair? A systematic review of overlapping meta-analyses.J Shoulder Elbow Surg. 2017 Sep; 26 (Epub 2017 Jun 12. PMID: 28619382): 1681-1691https://doi.org/10.1016/j.jse.2017.04.004
- Early versus delayed rehabilitation following arthroscopic rotator cuff repair: A systematic review.Phys Sportsmed. 2015 May; 43 (Epub 2015 Mar 22. PMID: 25797067): 178-187https://doi.org/10.1080/00913847.2015.1025683
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and their effect on musculoskeletal soft-tissue healing: A scoping review.JBJS Rev. 2019 Dec; 7 (PMID: 31851037): e4https://doi.org/10.2106/JBJS.RVW.19.00055
- Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study.Am J Sports Med. 2014 Dec; 42 (Epub 2014 Sep 2. PMID: 25184246): 2869-2876https://doi.org/10.1177/0363546514545856
- NSAID therapy effects on healing of bone, tendon, and the enthesis.J Appl Physiol (1985. 2013; 115 (2013/07/23): 892-899https://doi.org/10.1152/japplphysiol.00053.2013
- Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.J Pain Res. 2018 Feb 14; 11 (PMID: 29491719; PMCID: PMC5817415): 361-374https://doi.org/10.2147/JPR.S156938
- The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note.Epidemiol Psychiatr Sci. 2021; 30 (2021/12/03): e78https://doi.org/10.1017/s2045796021000664
- Updates on multimodal analgesia for orthopedic surgery.Anesthesiol Clin. 2018 Sep; 36 (Epub 2018 Jul 11. PMID: 30092934): 361-373https://doi.org/10.1016/j.anclin.2018.05.001
- Comparison of oral ketorolac and hydrocodone for pain relief after anterior cruciate ligament reconstruction.Arthroscopy. 1998; 14 (1998/10/01): 605-612https://doi.org/10.1016/s0749-8063(98)70057-x
- Intraarticular administration of ketorolac, morphine, and ropivacaine combined with intraarticular patient-controlled regional analgesia for pain relief after shoulder surgery: a randomized, double-blind study.Anesth Analg. 2008 Jan; 106 (table of contents. PMID: 18165599): 328-333https://doi.org/10.1213/01.ane.0000297297.79822.00
- Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease.J Shoulder Elbow Surg. 2009 Nov–Dec; 18 (Epub 2009 Jun 16. PMID: 19535272): 927-932https://doi.org/10.1016/j.jse.2009.03.021
- Establishing clinically significant outcome after arthroscopic rotator cuff repair.J Shoulder Elbow Surg. 2019 May; 28 (Epub 2019 Jan 24. PMID: 30685283): 939-948https://doi.org/10.1016/j.jse.2018.10.013
- Preoperative NSAIDs, non-acute onset and long-standing symptoms predict inferior outcome at long-term follow-up after rotator cuff repair.Knee Surg Sports Traumatol Arthrosc. 2017 Jul; 25 (Epub 2015 Oct 31. PMID: 26520644): 2067-2072https://doi.org/10.1007/s00167-015-3845-8
Article info
Publication history
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy